Answers are grounded in this paper and cite their sources.
Endovascular therapy (EVT) with devices such as drug-coated balloons (DCBs) and drug-eluting stents (DESs) for atherosclerotic disease in the femoropopliteal (FP) artery has been established. However, EVT using drug-based devices for chronic limb-threatening ischemia (CLTI) remains challenging. The optimal device for FP lesions in patients with CLTI remains unknown. This study compared the clinical efficacy of DCB and DES in patients with CLTI and FP lesions.
No takes yet. Share an insight, caveat, or question.
Ogata et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: